A Comprehensive Analysis of Interferon Regulatory Factor Expression: Correlation with Immune Cell Infiltration and Patient Prognosis in Endometrial Carcinoma

Figure 2

Expression of IRFs in endometrial carcinoma (EC) and normal endometrial samples. (a and b) Expression of IRF1 in paired and unpaired EC and normal endometrial samples, respectively. (c and d) Expression of IRF2 in paired and unpaired EC and normal endometrial samples, respectively. (e and f) Expression of IRF3 in paired and unpaired EC and normal endometrial samples, respectively. (g and h) Expression of IRF4 in paired and unpaired EC and normal endometrial samples, respectively. (i and g) Expression of IRF5 in paired and unpaired EC and normal endometrial samples, respectively. (k and l) Expression of IRF6 in paired and unpaired EC and normal endometrial samples, respectively. (m and n) Expression of IRF7 in paired and unpaired EC and normal endometrial samples, respectively. (o and p) Expression of IRF8 in paired and unpaired EC and normal endometrial samples, respectively. (q and r) Expression of IRF9 in paired and unpaired EC and normal endometrial samples, respectively.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)

(o)

(p)

(q)

(r)